Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: What to do?

2Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

This case report presents the case of a 29 weeks pregnant woman in her late twenties who was seen at the emergency department of a hospital with a seizure of unknown cause. By anamnesis and hetero-anamnesis the use of illicit gamma-hydroxybutyric acid (GHB) was revealed. Examination showed dilated pupils, sweating, tremor, tachycardia and bradyphrenic thinking. Subsequently, the seizure was indicated as a severe illicit GHB withdrawal symptom. Thereafter, treatment had to be decided on in the absence of evidence-based and practiced-based guidelines and treatment options for this specific patient population. Initially diazepam was started, which was later on substituted by sodium oxybate. Despite the critical professional situation the patient gave birth to a healthy daughter after 37 weeks of pregnancy.

Cite

CITATION STYLE

APA

Van Mechelen, J. C., Dijkstra, B. A. G., & Vergouwen, A. C. M. (2019). Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: What to do? BMJ Case Reports, 12(12). https://doi.org/10.1136/bcr-2019-230997

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free